A possible explanation was as follows: RGS1 was known to facilitate immune cell maturation and infiltration; thus, it was positively linked with the aforementioned tumour‐infiltrating immune cells in NSCLC patients.24, 25. The gene discussed is RGS1; the disease is non-small cell lung carcinoma.